Association of changes in circulating cell-free plasma DNA (cfDNA) and circulating tumor cells (CTC) during treatment with clinical outcome from olaparib in castration-resistant prostate cancer (CRPC): Exploratory analyses from the TOPARP-A trial.

Joaquin Mateo, Suneil Jain, Emma Hall, Johann S de Bono

Research output: Contribution to conferencePaper

Original languageEnglish
Pages141
Publication statusPublished - 20 Feb 2017
EventGU ASCO Symposium - F, Orlando, United States
Duration: 09 Feb 201711 Feb 2017

Conference

ConferenceGU ASCO Symposium
Abbreviated titleGU ASCO
CountryUnited States
CityOrlando
Period09/02/201711/02/2017

Cite this